ClinicalTrials.Veeva

Menu

ReActivate: Physiotherapist Led Intervention for Adolescents With Pain and Psychological Distress.

Ö

Örebro University, Sweden

Status

Enrolling

Conditions

Emotional Distress
Chronic Pain

Treatments

Behavioral: Reactivate

Study type

Interventional

Funder types

Other

Identifiers

NCT06410963
Reactivate

Details and patient eligibility

About

Recurrent or persistent pain and psychological distress are alarmingly common problems among adolescents, in Sweden as well as globally. They often co-occur and have been shown to be predictors of sustained problems in adulthood. Adequate treatment early on in the development of problems has been shown important in order to decrease the risk of sustained problems in adulthood but available treatments have only modest effects. There is thus a need for treatment development, not in the least for (secondary) preventative purposes. The aim of this project is therefore to develop an evidence based and cost-effective secondary preventative intervention. Specifically, this project aims to develop and test a physiotherapist led treatment for adolescents with recurrent or persistent pain and psychological distress based upon graded exposure to physical activity and reactivation.

Full description

See description of arms and intervention.

Enrollment

35 estimated patients

Sex

All

Ages

12 to 19 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 12-19
  • Psychological distress, such as anxiety, depressive symptoms or stress, ≥2 on a numeric rating scale 0-6 (0=not at all, 6=to a great extent)
  • Persistent (consistently or weekly recurrent) musculoskeletal pain problems for ≥3 months, with pain intensity ≥2 on a numeric rating scale 0-6 (0=not at all, 6=to a great extent)
  • Presence of avoidance behaviour and/or or worry about symptoms/problems, ≥1 on a numeric rating scale 0-6 (0=not at all, 6=to a great extent); > 50 on at least one activity of the PHODA.
  • Swedish speaking and able to fill out questionnaires

Exclusion criteria

  • Serious/malignant disease
  • Participation in other rehabilitation program
  • Severe mental health problems
  • Substance abuse
  • Severe learning disabilities

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

35 participants in 2 patient groups

No treatment waiting period
No Intervention group
Description:
Participants are randomized to a 7, 14 or 21 day waiting period. Daily measurements are collected throughout this period.
Reactivate
Experimental group
Description:
Reactivate treatment. Daily measurements are collected throughout treatment.
Treatment:
Behavioral: Reactivate

Trial contacts and locations

1

Loading...

Central trial contact

Tove Axelsson-Landberg, MSc; Emma Nilsing-Strid, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems